Neuromodulation Devices Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL NEUROMODULATION DEVICES INDUSTRY

2.1 Summary about Neuromodulation Devices Industry

2.2 Neuromodulation Devices Market Trends

2.2.1 Neuromodulation Devices Production & Consumption Trends

2.2.2 Neuromodulation Devices Demand Structure Trends

2.3 Neuromodulation Devices Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 Deep Brain Stimulation (DBS) Systems

4.2.2 Spinal Cord Stimulator (SCS) Systems

4.2.3 Diaphragm Pacing System (DPS)

4.2.4 Respiratory Electrical Stimulation (RES)

4.2.5 Vagus Nerve Stimulation (VNS)

4.2.6 Gastric Electrical Stimulation (GES)

4.2.7 Transcranial Magnetic Stimulation (TMS)

4.2.8 Transcutaneous Electrical Nerve Stimulation (TENS)

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Chronic Pain

4.3.2 Parkinson's Disease

4.3.3 Urine Incontinence

4.3.4 Epilepsy

4.3.5 Others

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 Deep Brain Stimulation (DBS) Systems

5.2.2 Spinal Cord Stimulator (SCS) Systems

5.2.3 Diaphragm Pacing System (DPS)

5.2.4 Respiratory Electrical Stimulation (RES)

5.2.5 Vagus Nerve Stimulation (VNS)

5.2.6 Gastric Electrical Stimulation (GES)

5.2.7 Transcranial Magnetic Stimulation (TMS)

5.2.8 Transcutaneous Electrical Nerve Stimulation (TENS)

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Chronic Pain

5.3.2 Parkinson's Disease

5.3.3 Urine Incontinence

5.3.4 Epilepsy

5.3.5 Others

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 Deep Brain Stimulation (DBS) Systems

6.2.2 Spinal Cord Stimulator (SCS) Systems

6.2.3 Diaphragm Pacing System (DPS)

6.2.4 Respiratory Electrical Stimulation (RES)

6.2.5 Vagus Nerve Stimulation (VNS)

6.2.6 Gastric Electrical Stimulation (GES)

6.2.7 Transcranial Magnetic Stimulation (TMS)

6.2.8 Transcutaneous Electrical Nerve Stimulation (TENS)

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Chronic Pain

6.3.2 Parkinson's Disease

6.3.3 Urine Incontinence

6.3.4 Epilepsy

6.3.5 Others

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 Deep Brain Stimulation (DBS) Systems

7.2.2 Spinal Cord Stimulator (SCS) Systems

7.2.3 Diaphragm Pacing System (DPS)

7.2.4 Respiratory Electrical Stimulation (RES)

7.2.5 Vagus Nerve Stimulation (VNS)

7.2.6 Gastric Electrical Stimulation (GES)

7.2.7 Transcranial Magnetic Stimulation (TMS)

7.2.8 Transcutaneous Electrical Nerve Stimulation (TENS)

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Chronic Pain

7.3.2 Parkinson's Disease

7.3.3 Urine Incontinence

7.3.4 Epilepsy

7.3.5 Others

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 Deep Brain Stimulation (DBS) Systems

8.2.2 Spinal Cord Stimulator (SCS) Systems

8.2.3 Diaphragm Pacing System (DPS)

8.2.4 Respiratory Electrical Stimulation (RES)

8.2.5 Vagus Nerve Stimulation (VNS)

8.2.6 Gastric Electrical Stimulation (GES)

8.2.7 Transcranial Magnetic Stimulation (TMS)

8.2.8 Transcutaneous Electrical Nerve Stimulation (TENS)

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Chronic Pain

8.3.2 Parkinson's Disease

8.3.3 Urine Incontinence

8.3.4 Epilepsy

8.3.5 Others

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 Deep Brain Stimulation (DBS) Systems

9.2.2 Spinal Cord Stimulator (SCS) Systems

9.2.3 Diaphragm Pacing System (DPS)

9.2.4 Respiratory Electrical Stimulation (RES)

9.2.5 Vagus Nerve Stimulation (VNS)

9.2.6 Gastric Electrical Stimulation (GES)

9.2.7 Transcranial Magnetic Stimulation (TMS)

9.2.8 Transcutaneous Electrical Nerve Stimulation (TENS)

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Chronic Pain

9.3.2 Parkinson's Disease

9.3.3 Urine Incontinence

9.3.4 Epilepsy

9.3.5 Others

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 Medtronic

10.1.2 Boston Scientific Corporation

10.1.3 St.Jude Medical

10.1.4 Synapse Biomedical

10.1.5 Nevro

10.1.6 Neurosigma

10.1.7 Neuropace

10.1.8 Neuronetics

10.1.9 Cyberonics

10.1.10 BioControl Medical

10.2 Neuromodulation Devices Sales Date of Major Players (2017-2020e)

10.2.1 Medtronic

10.2.2 Boston Scientific Corporation

10.2.3 St.Jude Medical

10.2.4 Synapse Biomedical

10.2.5 Nevro

10.2.6 Neurosigma

10.2.7 Neuropace

10.2.8 Neuronetics

10.2.9 Cyberonics

10.2.10 BioControl Medical

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

Table Neuromodulation Devices Product Type Overview

Table Neuromodulation Devices Product Type Market Share List

Table Neuromodulation Devices Product Type of Major Players

Table Brief Introduction of Medtronic

Table Brief Introduction of Boston Scientific Corporation

Table Brief Introduction of St.Jude Medical

Table Brief Introduction of Synapse Biomedical

Table Brief Introduction of Nevro

Table Brief Introduction of Neurosigma

Table Brief Introduction of Neuropace

Table Brief Introduction of Neuronetics

Table Brief Introduction of Cyberonics

Table Brief Introduction of BioControl Medical

Table Products & Services of Medtronic

Table Products & Services of Boston Scientific Corporation

Table Products & Services of St.Jude Medical

Table Products & Services of Synapse Biomedical

Table Products & Services of Nevro

Table Products & Services of Neurosigma

Table Products & Services of Neuropace

Table Products & Services of Neuronetics

Table Products & Services of Cyberonics

Table Products & Services of BioControl Medical

Table Market Distribution of Major Players

Table Global Major Players Sales Revenue (Million USD) 2017-2020e

Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

Table Global Neuromodulation Devices Market Forecast (Million USD) by Region 2021f-2026f

Table Global Neuromodulation Devices Market Forecast (Million USD) Share by Region 2021f-2026f

Table Global Neuromodulation Devices Market Forecast (Million USD) by Demand 2021f-2026f

Table Global Neuromodulation Devices Market Forecast (Million USD) Share by Demand 2021f-2026f